GCK 1026 is primarily used in research settings as a selective modulator of specific cellular pathways, particularly those involved in metabolic regulation. It shows potential in studying glucose metabolism and insulin signaling, making it a valuable tool in diabetes-related research. Its ability to target key enzymes involved in energy homeostasis allows scientists to investigate the molecular mechanisms underlying metabolic diseases. Additionally, GCK 1026 has been utilized in preclinical studies to evaluate the effects of enzyme activation on cellular glucose uptake and glycolytic flux. Due to its specificity, it aids in the development of novel therapeutic strategies aimed at metabolic syndrome and type 2 diabetes.